BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90.

Abstract:

:Clinical resistance to imatinib mesylate is commonly observed in patients with advanced Philadelphia chromosome- positive (Ph(+)) leukemias. Acquired resistance is typically associated with reactivation of BCR-ABL due to kinase domain mutations or gene amplification, indicating that BCR-ABL remains a viable target for inhibition in these patients. Strategies for overcoming resistance can be envisioned through exploitation of other molecular features of the BCR-ABL protein, such as its dependence on the molecular chaperone heat shock protein 90 (Hsp90). To determine whether inhibition of Hsp90 could induce degradation of imatinib mesylate-resistant, mutant BCR-ABL proteins, hematopoietic cells expressing 2 mutant BCR-ABL proteins found in imatinib mesylate-resistant patients (T315I and E255K) were examined for sensitivity to geldanamycin and 17-allylaminogeldanamycin (17-AAG). Both compounds induced the degradation of wild-type and mutant BCR-ABL and inhibited cell growth, with a trend indicating more potent activity against mutant BCR-ABL proteins. These data support clinical investigations of 17-AAG in imatinib mesylate-resistant Ph(+) leukemias.

journal_name

Blood

journal_title

Blood

authors

Gorre ME,Ellwood-Yen K,Chiosis G,Rosen N,Sawyers CL

doi

10.1182/blood-2002-05-1361

subject

Has Abstract

pub_date

2002-10-15 00:00:00

pages

3041-4

issue

8

eissn

0006-4971

issn

1528-0020

journal_volume

100

pub_type

杂志文章

相关文献

BLOOD文献大全
  • High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis.

    abstract::High-dose chemoradiotherapy (HDT) with autologous stem cell transplantation (ASCT) is the treatment of choice for patients with relapsed aggressive non-Hodgkin lymphoma (NHL). However, its role in the treatment of patients with primary refractory disease is not well defined. The outcomes of 85 patients with primary re...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kewalramani T,Zelenetz AD,Hedrick EE,Donnelly GB,Hunte S,Priovolos AC,Qin J,Lyons NC,Yahalom J,Nimer SD,Moskowitz CH

    更新日期:2000-10-01 00:00:00

  • Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation.

    abstract::Production of a red blood cell's hemoglobin depends on mitochondrial heme synthesis. However, mature red blood cells are devoid of mitochondria and rely on glycolysis for ATP production. The molecular basis for the selective elimination of mitochondria from mature red blood cells remains controversial. Recent evidence...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-02-137398

    authors: Kundu M,Lindsten T,Yang CY,Wu J,Zhao F,Zhang J,Selak MA,Ney PA,Thompson CB

    更新日期:2008-08-15 00:00:00

  • alpha2beta1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell-specific manner.

    abstract::To define the role of the alpha2beta1 integrin in pathologic angiogenesis, we investigated tumor-associated growth and angiogenesis in wild-type and alpha2-null mice. Our findings reveal that the alpha2beta1 integrin plays an important role in angiogenesis via regulation of VEGFR1 expression. When challenged with B16F...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-06-094680

    authors: Zhang Z,Ramirez NE,Yankeelov TE,Li Z,Ford LE,Qi Y,Pozzi A,Zutter MM

    更新日期:2008-02-15 00:00:00

  • Transient response to imatinib mesylate (STI571) in a patient with the ETV6-ABL t(9;12) translocation.

    abstract::We report the transient response of a patient with the ETV6-ABL fusion gene to imatinib mesylate (STI571). A 38-year-old man was referred with an erroneous diagnosis of Philadelphia-positive chronic myeloid leukemia in blastic transformation for treatment with the ABL tyrosine kinase inhibitor, STI571. Further investi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.9.3465

    authors: O'Brien SG,Vieira SA,Connors S,Bown N,Chang J,Capdeville R,Melo JV

    更新日期:2002-05-01 00:00:00

  • Thromboprophylaxis in cancer outpatients.

    abstract::In this issue of Blood, Khorana and colleagues report a simple and practical model for the prediction of symptomatic venous thrombosis after the initiation of chemotherapy in cancer outpatients. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2008-02-137760

    authors: Doggen CJ

    更新日期:2008-05-15 00:00:00

  • SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma.

    abstract::Mantle cell lymphoma (MCL) is one of the most aggressive lymphoid neoplasms whose pathogenesis is not fully understood. The neural transcription factor SOX11 is overexpressed in most MCL but is not detected in other mature B-cell lymphomas or normal lymphoid cells. The specific expression of SOX11 in MCL suggests that...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-06-438937

    authors: Vegliante MC,Palomero J,Pérez-Galán P,Roué G,Castellano G,Navarro A,Clot G,Moros A,Suárez-Cisneros H,Beà S,Hernández L,Enjuanes A,Jares P,Villamor N,Colomer D,Martín-Subero JI,Campo E,Amador V

    更新日期:2013-03-21 00:00:00

  • OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells.

    abstract::Aberrant regulation of endogenous survival pathways plays a major role in progression of chronic lymphocytic leukemia (CLL). Signaling via conjugation of surface receptors within the tumor environmental niche activates survival and proliferation pathways in CLL. Of these, the phosphoinositide 3-kinase (PI3K)/protein k...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-06-583518

    authors: Liu TM,Ling Y,Woyach JA,Beckwith K,Yeh YY,Hertlein E,Zhang X,Lehman A,Awan F,Jones JA,Andritsos LA,Maddocks K,MacMurray J,Salunke SB,Chen CS,Phelps MA,Byrd JC,Johnson AJ

    更新日期:2015-01-08 00:00:00

  • Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01.

    abstract::In a prospective trial in 284 children with B-lineage acute lymphoblastic leukemia (ALL), we assessed the clinical utility of real-time quantitative polymerase chain reaction analysis of antigen receptor gene rearrangements for detection of minimal residual disease (MRD) to identify children at high risk of relapse. A...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2006-09-045369

    authors: Zhou J,Goldwasser MA,Li A,Dahlberg SE,Neuberg D,Wang H,Dalton V,McBride KD,Sallan SE,Silverman LB,Gribben JG,Dana-Farber Cancer Institute ALL Consortium.

    更新日期:2007-09-01 00:00:00

  • Global gene expression analysis of human erythroid progenitors.

    abstract::Understanding the pattern of gene expression during erythropoiesis is crucial for a synthesis of erythroid developmental biology. Here, we isolated 4 distinct populations at successive erythropoietin-dependent stages of erythropoiesis, including the terminal, pyknotic stage. The transcriptome was determined using Affy...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-07-290825

    authors: Merryweather-Clarke AT,Atzberger A,Soneji S,Gray N,Clark K,Waugh C,McGowan SJ,Taylor S,Nandi AK,Wood WG,Roberts DJ,Higgs DR,Buckle VJ,Robson KJ

    更新日期:2011-03-31 00:00:00

  • Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation.

    abstract::c-MYC inhibits differentiation and regulates the process by which cells acquire biomass, cell growth. Down-regulation of c-MYC, reduced cell growth, and decreased activity of the PI3K/AKT/mTORC1 signal transduction pathway are features of the terminal differentiation of committed myeloid precursors to polymorphonuclea...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-111856

    authors: Wall M,Poortinga G,Hannan KM,Pearson RB,Hannan RD,McArthur GA

    更新日期:2008-09-15 00:00:00

  • Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation.

    abstract::Twenty-six patients with progressive Hodgkin's disease after conventional chemotherapy received intensive chemoradiotherapy and autologous bone marrow transplantation (ABMT); 19 also received additional involved-field radiotherapy. Twenty-one patients [81%, 95% confidence intervals (CI) 61% to 94%] attained complete (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Phillips GL,Wolff SN,Herzig RH,Lazarus HM,Fay JW,Lin HS,Shina DC,Glasgow GP,Griffith RC,Lamb CW

    更新日期:1989-06-01 00:00:00

  • A unique precipitating autoantibody against plasma thromboplastin antecedent associated with multiple apparent plasma clotting factor deficiencies in a patient with systemic lupus erythematosus.

    abstract::A 42-yr-old woman with systemic lupus erythematosus without bleeding diathesis developed a prolonged activated partial thromboplastin time that was not corrected by normal plasma. An inhibitor that acted rapidly and inactivated 0.5 U/ml plasma thromboplastin antecedent (PTA, factor XI) at a 1:200 plasma dilution was d...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Poon MC,Saito H,Koopman WJ

    更新日期:1984-06-01 00:00:00

  • How I conduct a comprehensive chronic graft-versus-host disease assessment.

    abstract::Since the National Institutes of Health Chronic Graft-Versus-Host Disease (cGVHD) Consensus Project in 2005, a need has emerged to evaluate cGVHD more methodically, not only to make a cGVHD diagnosis, but also to accurately classify individual organ and global organ severity, at baseline and in follow-up so that subje...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-04-314815

    authors: Carpenter PA

    更新日期:2011-09-08 00:00:00

  • Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells.

    abstract::The interleukin-6 receptor (IL-6R)/signal transducer and activator of transcription 3 (STAT3) pathway contributes to the pathogenesis of multiple myeloma (MM) and protects MM cells from apoptosis. However, MM cells survive the IL-6R blockade if they are cocultured with bone marrow stromal cells (BMSCs), suggesting tha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-04-1670

    authors: Chatterjee M,Stühmer T,Herrmann P,Bommert K,Dörken B,Bargou RC

    更新日期:2004-12-01 00:00:00

  • Scianna antigens including Rd are expressed by ERMAP.

    abstract::The Scianna blood group encompasses the high-frequency antigens Sc1 and Sc3 and the low-frequency antigen Sc2. Another low-frequency antigen Rd (Radin) was suggested to belong to the Scianna blood group. The molecular basis of the Scianna blood group was unknown. The erythrocyte membrane-associated protein (ERMAP) sha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-07-2064

    authors: Wagner FF,Poole J,Flegel WA

    更新日期:2003-01-15 00:00:00

  • An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.

    abstract::Mutations in HFE lead to hereditary hemochromatosis (HH) because of inappropriately high iron uptake from the diet resulting from decreased hepatic expression of the iron-regulatory hormone hepcidin. -thalassemia is a congenital anemia caused by partial or complete loss of -globin synthesis causing ineffective erythro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-09-453977

    authors: Schmidt PJ,Toudjarska I,Sendamarai AK,Racie T,Milstein S,Bettencourt BR,Hettinger J,Bumcrot D,Fleming MD

    更新日期:2013-02-14 00:00:00

  • Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment.

    abstract::Arsenic trioxide (As₂O₃) is a highly effective treatment for patients with refractory/relapsed acute promyelocytic leukemia (APL), but resistance to As₂O₃ has recently been seen. In the present study, we report the findings that 2 of 15 patients with refractory/relapsed APL treated with As₂O₃ were clinically As₂O₃ res...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-01-329433

    authors: Goto E,Tomita A,Hayakawa F,Atsumi A,Kiyoi H,Naoe T

    更新日期:2011-08-11 00:00:00

  • A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation.

    abstract::Translation of small interfering RNA (siRNA)-based approaches into practical therapeutics is limited because of lack of an effective and cell-specific delivery system. Herein, we present a new method of selectively delivering siRNA to dendritic cells (DCs) in vivo using CD40 siRNA-containing immunoliposomes (siILs) th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-04-151191

    authors: Zheng X,Vladau C,Zhang X,Suzuki M,Ichim TE,Zhang ZX,Li M,Carrier E,Garcia B,Jevnikar AM,Min WP

    更新日期:2009-03-19 00:00:00

  • Mutations of the N-ras gene in juvenile chronic myelogenous leukemia.

    abstract::Juvenile chronic myelogenous leukemia (JCML), a myeloproliferative disorder of childhood, is distinct from adult-type chronic myelogenous leukemia (CML) and bears resemblance to chronic myelomonocytic leukemia (CMMoL). Since mutations in the N-ras gene have been found at high frequencies in CMMoL, but only rarely in C...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miyauchi J,Asada M,Sasaki M,Tsunematsu Y,Kojima S,Mizutani S

    更新日期:1994-04-15 00:00:00

  • Regulation by alpha 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma.

    abstract::The effects of alpha 2-antiplasmin and fibrin on the activation of plasminogen by recombinant staphylokinase (STAR) were studied in an effort to elucidate further the molecular basis of the fibrin-specificity of this fibrinolytic agent. In purified systems consisting of 1.5 mumol/L intact or low-M(r) plasminogen and 3...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Silence K,Collen D,Lijnen HR

    更新日期:1993-08-15 00:00:00

  • Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells.

    abstract::Circulating endothelial cells (CECs) have been detected in association with endothelial injury and therefore represent proof of serious damage to the vascular tree. Our aim was to investigate, using the technique of immunomagnetic separation, whether the pathological events in unstable angina (UA) or acute myocardial ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mutin M,Canavy I,Blann A,Bory M,Sampol J,Dignat-George F

    更新日期:1999-05-01 00:00:00

  • Biotherapy for xenografted human central nervous system leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin.

    abstract::The study of central nervous system (CNS) leukemia has been hampered by the lack of a suitable animal model. We report that severe combined immunodeficiency (SCID) mice invariably develop rapidly progressive fatal CNS leukemia within 3 weeks after intravenous injection of NALM-6 pre-B acute lymphoblastic leukemia (ALL...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gunther R,Chelstrom LM,Tuel-Ahlgren L,Simon J,Myers DE,Uckun FM

    更新日期:1995-05-01 00:00:00

  • Inhibition of NF-kappaB by a TAT-NEMO-binding domain peptide accelerates constitutive apoptosis and abrogates LPS-delayed neutrophil apoptosis.

    abstract::Delivery of biologically active peptides into human polymorphonuclear neutrophils (PMNs) has implications for studying cellular functions and may be therapeutically relevant. The transcription factor nuclear factor-kappaB (NF-kappaB) regulates the expression of multiple genes controlling inflammation, proliferation, a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-09-2960

    authors: Choi M,Rolle S,Wellner M,Cardoso MC,Scheidereit C,Luft FC,Kettritz R

    更新日期:2003-09-15 00:00:00

  • The quantity and duration of FcRgamma signals determine mast cell degranulation and survival.

    abstract::Immunoglobulin E (IgE) bound to multivalent antigen (Ag) elicits mast cell degranulation but not survival; on the contrary, IgE in the absence of Ag (IgE(-Ag)) induces survival only but not degranulation. Although these distinct responses are mediated through the same receptor, FcepsilonRI, the molecular mechanism gen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-08-2944

    authors: Yamasaki S,Ishikawa E,Kohno M,Saito T

    更新日期:2004-04-15 00:00:00

  • Delta-like1-induced Notch1 signaling regulates the human plasmacytoid dendritic cell versus T-cell lineage decision through control of GATA-3 and Spi-B.

    abstract::Human early thymic precursors have the potential to differentiate into multiple cell lineages, including T cells and plasmacytoid dendritic cells (pDCs). This decision is guided by the induction or silencing of lineage-specific transcription factors. The ETS family member Spi-B is a key regulator of pDC development, w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-05-2090

    authors: Dontje W,Schotte R,Cupedo T,Nagasawa M,Scheeren F,Gimeno R,Spits H,Blom B

    更新日期:2006-03-15 00:00:00

  • Shared idiotype expression by chronic lymphocytic leukemia and B-cell lymphoma.

    abstract::Antiidiotype (Id) antibodies identify unique determinants within the surface immunoglobulin (Ig) that are present on B-cell tumors. Anti-Ids have been used for diagnosis and therapy of B-cell lymphoma and leukemia. A panel of 29 anti-Id monoclonal antibodies (MoAbs) that recognize shared idiotypes (SIds) on B-cell lym...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chatterjee M,Barcos M,Han T,Liu XL,Bernstein Z,Foon KA

    更新日期:1990-11-01 00:00:00

  • Identification of CCR9- murine plasmacytoid DC precursors with plasticity to differentiate into conventional DCs.

    abstract::Whereas the final differentiation of conventional dendritic cells (CDCs) from committed precursors occurs locally in secondary lymphoid or peripheral tissues, plasmacytoid dendritic cells (PDCs) are thought to fully develop in the bone marrow from common DC progenitors before migrating to the periphery. In our study, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-326678

    authors: Schlitzer A,Loschko J,Mair K,Vogelmann R,Henkel L,Einwächter H,Schiemann M,Niess JH,Reindl W,Krug A

    更新日期:2011-06-16 00:00:00

  • Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations.

    abstract::Pharmaceutical preparations of normal human immunoglobulin (IgG) are known to contain high-avidity and neutralizing antibodies (Ab) to the cytokines interleukin (IL)-1alpha, IL-6, and interferon (IFN)alpha. To test for other cytokine Ab, 23 batches of IgG were tested for saturable binding to eight 125I-labeled recombi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Svenson M,Hansen MB,Ross C,Diamant M,Rieneck K,Nielsen H,Bendtzen K

    更新日期:1998-03-15 00:00:00

  • Human CD34+ fetal liver stem cells differentiate to T cells in a mouse thymic microenvironment.

    abstract::Hematopoietic stem cells differentiate in the thymus to T cells along precisely defined intermediates. This process is thymic epithelium dependent and involves cytokines and cell-cell interactions between thymic stroma and T-cell precursors. Here we report that highly purified human CD34++ fetal liver stem cells diffe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Plum J,De Smedt M,Defresne MP,Leclercq G,Vandekerckhove B

    更新日期:1994-09-01 00:00:00

  • FCR achieves long-term durable remissions in patients with IGHV-mutated CLL.

    abstract::In chronic lymphocytic leukemia (CLL) patients with mutated IGHV, 3 recent studies have demonstrated prolonged progression-free survival (PFS) after treatment with fludarabine-cyclophosphamide-rituximab (FCR) chemoimmunotherapy. We performed a systematic review to assess the benefit of FCR for patients with CLL and id...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-07-731588

    authors: Chai-Adisaksopha C,Brown JR

    更新日期:2017-11-23 00:00:00